- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| EXTRAWELL PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 21.10. | EXTRAWELL PHAR (00858): GRANT OF SHARE OPTIONS TO DIRECTORS AND CONNECTED TRANSACTION AT SUBSIDIARY LEVEL IN RELATION TO THE GRANT OF SHARE OPTIONS TO ... | 1 | HKEx | ||
| 16.10. | EXTRAWELL PHAR (00858): TERMINATION OF THE MEMORANDUM OF UNDERSTANDING IN RELATION TO THE POSSIBLE SALE OF THE CONVERTIBLE BONDS | 3 | HKEx | ||
| 14.10. | EXTRAWELL PHAR (00858): PROPOSED SHARE CONSOLIDATION; PROPOSED CAPITAL REDUCTION; PROPOSED SHARE SUB-DIVISION AND PROPOSED CHANGE IN BOARD LOT SIZE | - | HKEx | ||
| 12.10. | EXTRAWELL PHAR (00858): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| 12.10. | EXTRAWELL PHAR (00858): APPOINTMENT OF EXECUTIVE DIRECTOR | 1 | HKEx | ||
| 30.09. | EXTRAWELL PHAR (00858): FURTHER EXTENSION OF LONG STOP DATE IN RESPECT OF PROPOSED FOURTH AMENDMENTS TO THE TERMS AND CONDITIONS OF THE BONDS | 3 | HKEx | ||
| 11.09. | EXTRAWELL PHAR (00858): FURTHER DELAY IN DESPATCH OF CIRCULAR IN RESPECT OF THE MAJOR TRANSACTION IN RELATION TO THE PROPOSED FOURTH AMENDMENTS TO THE ... | 1 | HKEx | ||
| 28.08. | EXTRAWELL PHAR (00858): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 28.08. | EXTRAWELL PHAR (00858): POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 AUGUST 2026 AND RETIREMENT OF DIRECTOR | - | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2026, CIRCULAR DATED 31 ... | 4 | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2026, CIRCULAR DATED 31 ... | 2 | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 28 AUGUST 2026 AT 11:00 A.M. | - | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): PROPOSALS FOR GENERAL MANDATES TO ISSUE NEW SHARES AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL ... | - | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): ANNUAL REPORT 2026 | 1 | HKEx | ||
| 30.06. | EXTRAWELL PHAR (00858): ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2026 | 1 | HKEx | ||
| 23.06. | EXTRAWELL PHAR (00858): PROFIT WARNING | - | HKEx | ||
| 16.06. | EXTRAWELL PHAR (00858): DATE OF BOARD MEETING | 2 | HKEx | ||
| 29.05. | EXTRAWELL PHAR (00858): (1) FURTHER EXTENSION OF LONG STOP DATE IN RESPECT OF PROPOSED FOURTH AMENDMENTS TO THE TERMS AND CONDITIONS OF THE BONDS (2) ... | - | HKEx |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS | 39,660 | -0,03 % | Ionis Pharmaceuticals stock price target maintained at $100 by H.C. Wainwright on HBV approval | ||
| CSPC PHARMA | 0,929 | +2,01 % | CSPC PHARMA Initiates Phase I Clinical Trial in China for SYS6077 Injection for Treatment of Advanced Malignant Tumors | ||
| SELLAS LIFE SCIENCES | 8,960 | +1,13 % | Sellas falls as REGAL trial nears final analysis | ||
| MADRIGAL PHARMACEUTICALS | 390,20 | +2,15 % | B.Riley bekräftigt Kaufempfehlung für Madrigal Pharmaceuticals - Kursziel von 670 Dollar im Visier | ||
| ACADIA PHARMACEUTICALS | 18,385 | +2,59 % | ACADIA PHARMACEUTICALS INC - 8-K, Current Report | ||
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| OPUS GENETICS | 3,180 | 0,00 % | Opus Genetics appoints chief scientific officer, operations head | ||
| SAVARA | 4,486 | +1,04 % | Savara Inc.: Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026 | -- Company to Host Industry Evening Mini-Symposium on aPAP with Renowned Key Opinion Leaders --Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases... ► Artikel lesen | |
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information | Northvale, New Jersey--(Newsfile Corp. - August 13, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| GALECTIN THERAPEUTICS | 3,060 | +4,08 % | Galectin Therapeutics Inc.: Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update | NORCROSS, Ga., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and... ► Artikel lesen | |
| BIODEXA PHARMACEUTICALS | 2,958 | -2,57 % | XFRA NEW INSTRUMENTS AVAILABLE ON 28.10.2026 | The following instruments on XETRA do have their first trading 28.10.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 28.10.2026
Aktien
1 US59564R8640 Biodexa Pharmaceuticals... ► Artikel lesen | |
| NEURIZON THERAPEUTICS | 0,045 | 0,00 % | XFRA ECQ0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNEURIZON THERAPEUTICS... ► Artikel lesen | |
| CIPHER PHARMACEUTICALS | 8,600 | -2,27 % | Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors | ||
| ACURA PHARMACEUTICALS | - | - | ACURA PHARMACEUTICALS, INC - 8-K, Current Report | ||
| VASO | - | - | Vaso Corporation Announces Financial Results for Second Quarter of 2026 | PLAINVIEW, N.Y., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a business portfolio in professional sales services and proprietary non-invasive... ► Artikel lesen |
Das Unternehmen EXTRAWELL PHARMACEUTICAL HOLDINGS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXTRAWELL PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.